Related Experiment Video
Updated: Dec 17, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
NEK10 tyrosine phosphorylates p53 and controls its transcriptional activity
Nasir Haider1,2, Previn Dutt2, Bert van de Kooij3
1Department of Medical Biophysics, Princess Margaret Cancer Research Tower, University of Toronto, Toronto, ON, M5G 1L7, Canada.
Abstract:
In response to genotoxic stress, multiple kinase signaling cascades are activated, many of them directed towards the tumor suppressor p53, which coordinates the DNA damage response (DDR). Defects in DDR pathways lead to an accumulation of mutations that can promote tumorigenesis. Emerging evidence implicates multiple members of the NimA-related kinase (NEK) family (NEK1, NEK10, and NEK11) in the DDR. Here, we describe a function for NEK10 in the regulation of p53 transcriptional activity through tyrosine phosphorylation. NEK10 loss increases cellular proliferation by modulating the p53-dependent transcriptional output. NEK10 directly phosphorylates p53 on Y327, revealing NEK10's unexpected substrate specificity. A p53 mutant at this site (Y327F) acts as a hypomorph, causing an attenuated p53-mediated transcriptional response. Consistently, NEK10-deficient cells display heightened sensitivity to DNA-damaging agents. Further, a combinatorial score of NEK10 and TP53-target gene expression is an independent predictor of a favorable outcome in breast cancers.
Insights
NimA-related kinase 10 (NEK10) regulates the tumor suppressor p53
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Genotoxic stress activates kinase signaling cascades, including those targeting the tumor suppressor p53, crucial for the DNA damage response (DDR).
- Defects in DDR pathways contribute to mutation accumulation and tumorigenesis.
- Members of the NimA-related kinase (NEK) family, such as NEK1, NEK10, and NEK11, are implicated in DDR pathways.
Purpose of the Study:
- To investigate the role of NEK10 in the DNA damage response (DDR).
- To elucidate the mechanism by which NEK10 regulates p53 transcriptional activity.
- To determine the clinical relevance of NEK10 in breast cancer prognosis.
Main Methods:
- Investigated NEK10's function in regulating p53 transcriptional activity via tyrosine phosphorylation.
- Analyzed the effect of NEK10 loss on cellular proliferation and p53-dependent transcription.
- Utilized p53 mutants (Y327F) to assess the impact of phosphorylation at Y327.
- Assessed sensitivity of NEK10-deficient cells to DNA-damaging agents.
- Correlated NEK10 and TP53-target gene expression with breast cancer outcomes.
Main Results:
- NEK10 directly phosphorylates p53 on tyrosine 327 (Y327), demonstrating specific substrate recognition.
- Loss of NEK10 leads to increased cellular proliferation by altering p53-dependent transcriptional output.
- A p53 Y327F mutant exhibits hypomorphic activity, resulting in an attenuated p53-mediated transcriptional response.
- NEK10-deficient cells show increased sensitivity to DNA-damaging agents.
- A combined score of NEK10 and TP53-target gene expression independently predicts favorable outcomes in breast cancer.
Conclusions:
- NEK10 plays a critical role in regulating p53 transcriptional activity through direct phosphorylation at Y327.
- NEK10-mediated regulation of p53 impacts cellular proliferation and DNA damage sensitivity.
- NEK10 and its downstream targets represent potential biomarkers for predicting breast cancer prognosis.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
PI3K/mTOR/AKT Signaling Pathway
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle

